Carbohydrate assimilation

Carbohydrate assimilation is a physiological process rather than a single molecular target, encompassing the breakdown of complex dietary carbohydrates into monosaccharides and their subsequent transport into the bloodstream (NCBI Bookshelf, NBK554394). The process begins with the action of alpha-amylase in the saliva and pancreas, which hydrolyzes starches into smaller oligosaccharides. These are further processed by brush border enzymes in the small intestine, such as alpha-glucosidase (sucrase-isomaltase and maltase-glucoamylase), into simple sugars like glucose, fructose, and galactose (StatPearls, 2023). Absorption is then mediated by specialized transporters, including the Sodium-Glucose Linked Transporter 1 (SGLT1) for glucose and galactose, and Glucose Transporter 5 (GLUT5) for fructose, before they exit into the portal circulation via GLUT2 (PubMed, 2697001). In the context of pharmacotherapy, modulating carbohydrate assimilation is a strategic approach for managing Type 2 Diabetes Mellitus. Alpha-glucosidase inhibitors, such as Acarbose and Miglitol, act by competitively inhibiting the enzymes responsible for carbohydrate hydrolysis, thereby slowing the rate of glucose entry into the systemic circulation and reducing postprandial hyperglycemia (Mayo Clinic, 2024). While effective in managing glycemic excursions, the presence of undigested carbohydrates in the lower intestine can lead to osmotic effects and bacterial fermentation, resulting in common side effects like flatulence and diarrhea. Because the term refers to a complex multi-step pathway involving multiple distinct enzymes and transporters, it is classified as a biological process rather than a specific therapeutic target molecule.

Other names

Carbohydrate digestion and absorptionIntestinal carbohydrate absorptionSugar assimilationStarch and sucrose metabolism

Inhibition of intestinal enzymes such as alpha-glucosidase and alpha-amylase to delay the hydrolysis of complex carbohydrates into glucose, or inhibition of transporters like SGLT1 to reduce glucose uptake.